28/07/2026
Today, we had the privilege of welcoming Professor James St John from Griffith University to The Next Step to share the latest updates on the world’s first Nerve Bridge Clinical Trial for spinal cord injury.
After years of research, planning and refining the process, it finally feels like we’re talking about when, not if.
Some of the biggest updates from today’s session:
• First participants are expected to begin pre-screening later this year, with the first transplants planned for early next year.
• More than 700 people have already registered their Expression of Interest.
• The treatment uses a person’s own cells from inside their nose to create a nerve bridge that is implanted into the spinal cord.
• Rehabilitation before and after surgery will be a vital part of the trial, with programs tailored to each participant.
• Every delay has been about improving safety and giving participants the best possible treatment.
Today was a reminder that while there’s still a long road ahead, real progress is being made, and that’s something worth feeling hopeful about.
A huge thank you to Professor James St John for taking the time to answer our community’s questions so openly, and thank you to everyone who joined us today.
For more information, or to register your Expression of Interest for the trial, visit:
https://www.griffith.edu.au/research/institute-biomedicine-glycomics/clem-jones-centre/themes/spinal-cord-injury-nerve-bridge-transplantation-trial